We, Melone Pharmaceutical Co., Ltd, is mainly focus on R&D, manufacturing and marketing for New APIs and its intermediates. Our strong products are as follows: Bimatoprost, Bortzomib and its intermediates, CEP18770, daptomycin, Decitabine, Doxorubicin HCl, Epirubicin HCl, Latanoprost, Lubiprostone, Pazopanib, Rapamycin, Retigabine, Impurity and Isomers for Bortezomib and its intermediates, (R)-BoroLeu-(+)-Pinanediol-CF3CO2H (Cas No.179324-87-9); For Bimatoprost, Travoprost and Latanoprost, we already has its DMF document.